With the analysis among 40 patents, we discovered top 12 key players by total patent application. GlaxoSmithKline Biologicals SA, BioNTech SE, Celldex Therapeutics, Inc. are dominant in this area. They take 65.00% of the total patent filing.
Rheinland-Pfalz, Germany
Patent: 4
New Jersey, United States
Patent: 3
New Jersey, United States
Patent: 2
Xetrios Therapeutics, Inc.
California, United States
Patent: 2
Rheinland-Pfalz, Germany
Patent: 2
Vaud, Switzerland
Patent: 1
No data, please try another search term
With the analysis among related 9 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing TRON - Translationale Onkologie an der Universitätsmedizin der, BioNTech SE, BioNTech RNA Pharmaceuticals GmbH take 122.22% of patent filing during this period.
Rheinland-Pfalz, Germany
Patent: 5
Rheinland-Pfalz, Germany
Patent: 4
Rheinland-Pfalz, Germany
Patent: 2
Tennessee, United States
Patent: 1
Vaud, Switzerland
Patent: 1
New York, United States
Patent: 1
With the analysis among related 9 patents in last 5 years, we discover 4 new entrants. TRON - Translationale Onkologie an der Universitätsmedizin der, BioNTech SE, BioNTech RNA Pharmaceuticals GmbH are the most active new entrants in this area.
Rheinland-Pfalz, Germany
Patent: 5
Rheinland-Pfalz, Germany
Patent: 4
Rheinland-Pfalz, Germany
Patent: 2
Vaud, Switzerland
Patent: 1
With the analysis among 60 patents, we discovered top 8 universities and scientific research institutions by total patent application. Icahn School of Medicine at Mount Sinai, The Salk Institute for Biological Studies, University of Kentucky are dominant in this area. They take 108.33% of the total patent filing.
New York, United States
Patent: 46
California, United States
Patent: 4
Kentucky, United States
Patent: 3
Nordrhein-Westfalen, Germany
Patent: 3
New York, United States
Patent: 2
Basel-Stadt, Switzerland
Patent: 2
Hiroshima-ken, Japan
Patent: 1
Massachusetts, United States
Patent: 1